This proposal focusses on the role of HIV in the pathogenesis of AIDS and AIDS-associated B-cell neoplasms. The proposed program project consists of six inter-related projects aimed at understanding the role of HIV in the etiology, pathogenesis and progression of AIDS and AIDS-associated cancers. We proposed to use the technique of site-directed mutagenesis to alter the aminoacid sequence of the envelope gene and test the resulting mutants for the abrogation of T4 binding, multinucleated giant cell formation and loss of T-cell cytotoxicity. We will also use several synthetic peptides homologous to the various domains of the envelope protein for their ability to block T4 binding or inhibit the ability of the virus to induce cell fusion. Synthetic peptides will also be used to map the antigenic sites on the envelope protein that are capable of inducing neutralizing antibody activity. Monoclonal antibodies raised against the synthetic peptides will in turn be used for the derivation of anti-idiotypic antibodies and their potential use as vaccines will be tested. To understand the role of other viral and cellular genes in the pathogenesis of AIDS, we will study the effect of CMV on HIV replication in vitro and in vivo. As a complement to the in vitro studies, HIV-infected infants, HIV-infected hemophiliac children and aymptomatic HIV-infected patients will be followed longitudinally to observe the effect of intercurrent CMV infection on the clinical course and replication of HIV. Finally, we will also investigate the role of cellular oncogenes, c-myc, bcl-1 and bcl-2 in the induction of virologists, geneticists, biochemists and clinicians with a common interest in the pathogenesis of AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI025380-02
Application #
3091836
Study Section
(SRC)
Project Start
1987-09-30
Project End
1992-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sperlagh, M; Hoxie, J; Maruyama, H et al. (1994) Polyclonal antiidiotypic antibodies mimicking gp120 of HIV-1. Viral Immunol 7:61-9
Reddy, M V; Desai, M; Jeyapaul, J et al. (1992) Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1. Oncogene 7:1743-8
Dasgupta, P; Reddy, C D; Saikumar, P et al. (1992) The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type I. J Virol 66:270-6
Nagashunmugam, T; Velpandi, A; Goldsmith, C S et al. (1992) Mutation in the primer binding site of the type 1 human immunodeficiency virus genome affects virus production and infectivity. Proc Natl Acad Sci U S A 89:4114-8
Kasai, Y; Herlyn, D; Sperlagh, M et al. (1992) Molecular cloning of murine monoclonal anti-idiotypic Fab. J Immunol Methods 155:77-89
Nagashunmugam, T; Velpandi, A; Otsuka, T et al. (1992) Analysis of the viral determinants underlying replication kinetics and cellular tropism of human immunodeficiency virus. Pathobiology 60:234-45
Velpandi, A; Nagashunmugam, T; Otsuka, T et al. (1992) Structure-function studies of HIV-1: influence of long terminal repeat U3 region sequences on virus production. DNA Cell Biol 11:369-76
Hoxie, J A (1991) Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins. AIDS Res Hum Retroviruses 7:495-9
Jeyapaul, J; Seshamma, T; Khan, S A (1991) Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction. Oncogene 6:1507-13
Inoue, M; Hoxie, J A; Reddy, M V et al. (1991) Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses. Proc Natl Acad Sci U S A 88:2278-82

Showing the most recent 10 out of 20 publications